CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 96 filers reported holding CYTOSORBENTS CORP in Q3 2021. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $31,000 | -24.4% | 9,801 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $41,000 | -48.8% | 9,801 | 0.0% | 0.00% | -66.7% |
| Q3 2021 | $80,000 | +8.1% | 9,801 | 0.0% | 0.00% | +50.0% |
| Q2 2021 | $74,000 | -12.9% | 9,801 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $85,000 | +9.0% | 9,801 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $78,000 | 0.0% | 9,801 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $78,000 | -19.6% | 9,801 | 0.0% | 0.00% | -25.0% |
| Q2 2020 | $97,000 | – | 9,801 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 964,141 | $7,829,000 | 1.90% |
| Skylands Capital, LLC | 1,837,541 | $14,921,000 | 1.84% |
| CM Management, LLC | 175,000 | $1,421,000 | 1.06% |
| Soleus Capital Management, L.P. | 800,000 | $6,496,000 | 1.01% |
| Avenir Corp | 1,395,385 | $11,331,000 | 0.95% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 185,000 | $1,502,000 | 0.55% |
| Winning Points Advisors, LLC | 86,200 | $701,000 | 0.51% |
| Granahan Investment Management | 1,154,561 | $9,375,000 | 0.18% |
| SECTORAL ASSET MANAGEMENT INC | 244,660 | $1,987,000 | 0.16% |
| Redmile Group, LLC | 1,044,434 | $8,481,000 | 0.15% |